REGENXBIO Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
REGENXBIO Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • REGENXBIO Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $55.3M, a 10.5% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $55.3M -$6.48M -10.5% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $56.3M -$6.09M -9.76% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $57.6M -$6.17M -9.68% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $60.5M -$4.63M -7.11% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 $61.8M +$2.3M +3.87% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $62.4M +$2.27M +3.78% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $63.7M +$3.8M +6.34% Mar 31, 2023 10-Q 2023-05-03
Q4 2022 $65.1M +$4.21M +6.92% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $59.5M -$2.27M -3.68% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $60.2M -$2.12M -3.4% Jun 30, 2022 10-Q 2022-08-03
Q1 2022 $59.9M -$2.68M -4.28% Mar 31, 2022 10-Q 2022-05-04
Q4 2021 $60.9M -$2.91M -4.56% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $61.7M +$3.92M +6.77% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $62.3M +$53.6M +621% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $62.6M +$53.2M +568% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $63.8M +$53.7M +533% Dec 31, 2020 10-K 2022-03-01
Q3 2020 $57.8M +$51.9M +879% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 $8.64M +$2.73M +46.3% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $9.38M +$2.52M +36.7% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $10.1M Dec 31, 2019 10-K 2021-03-01
Q3 2019 $5.91M Sep 30, 2019 10-Q 2019-11-05
Q2 2019 $5.9M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $6.86M Mar 31, 2019 10-Q 2019-05-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.